Interestingly, the activation of TLR2 in the immunodominant cytotoxic T lymphocyte response to the spike glycoprotein of SARS-CoV-2, which is also produced by COVID-19 vaccines, was described [120]. This evidence concerns the gene TLR2 and COVID-19.